SUVEN LIFE SCIENCES LTD. - 530239 - Appointment of Company Secretary and Compliance Officer
Changes in KMPs of Suven Group companies and Change in Directorship of SLSL10-01-2020
10-01-2020
Suven Life Sciences Ltd - 530239 - Intimation Of Record Date Pursuant To Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to the above subject, pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 10th January, 2020, has taken on record and approved the following matter: We wish to inform you that consequent to Scheme of Arrangement (Demerger) sanctioned by the Hon'ble National Company Law Tribunal, Bench at Hyderabad ("NCLT") the said scheme became operational w.e.f. 9th January, 2020 having consideration of the transfer and vesting of the of Demerged Undertaking (as defined in the Scheme) from SLSL to SPL in terms of the Scheme, the Equity Shareholders of the Company whose names recorded in the Register of Members and records of the depositories as a member of the Company as on Wednesday, January 22, 2020 being the Record Date fixed by the Board, will be entitled for allotment of:10-01-2020
Suven Life Sciences Ltd - 530239 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received intimation from our RTA dtd. 07-01-2020 regarding issued duplicate share certificate(s) in lieu of the loss of original share certificate(s) to the following shareholders(s)08-01-2020
Suven Life Sciences share price rises 3% on NCLT nod for Scheme of Arrangement
The contract research and manufacturing services undertaking (including its respective assets and liabilities) of the company will be transferred to Suven Pharmaceuticals by way of demerger.07-01-2020
SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we would like to inform you that on January 6, 2020 the Hon''ble National Company Law Tribunal, Bench at Hyderabad ("NCLT") has passed order allowing the Company Petition filed for sanction of the Composite Scheme of Arrangement ('Scheme') under Sections 230 to 232 read with Section 66 and other applicable provisions of the Companies Act, 2013 amongst Suven Life Sciences Limited ('Demerged Company') and Suven Pharmaceuticals Limited ('Resulting Company') and their respective Shareholders and Creditors07-01-2020
Suven Life Sciences Ltd - 530239 - Closure of Trading Window
We wish to inform you that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives covered under the said Code of the Company from 1st January, 2020 and the same will remain closed till 48 hours after the declaration of Financial Results for the third quarter and nine months ending 31st December, 2019, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.31-12-2019
Company news: Suven Life Sciences
Suven Life Sciences on Thursday said that the USFDA, after inspecting its facility recently at Pashamylaram, Hyderabad, issued an Establishment Inspec19-12-2019
SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven receives EIR from US FDA for its Pashamylaram facility19-12-2019
Suven Life Sciences Ltd - 530239 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received intimation from our RTA (KFin Technologies Private Limited) regarding loss of share certificate(s) from the following shareholders(s). A copy of intimation from RTA is enclosed herewith.17-12-2019
Suven Life Sciences Ltd - 530239 - Intimation Of Change In Name Of Registrar And Share Transfer Agent From Karvy Fintech Private Limited To Kfin Technologies Private Limited
This is to inform that the Company has been informed by our Registrar and Share Transfer Agent that they have changed their name from Karvy Fintech Private Limited to KFin Technologies Private Limited with effect from December 5, 2019. We request you to take note of the same and update the name of KFin Technologies Private Limited as the Registrar and Share Transfer Agent of the Company in your records.10-12-2019